Skip to main content

Table 2 Data from 46 salvage lymph node dissections from 43 patients with nodal prostate cancer relapse

From: Toxicity and quality of life after choline-PET/CT directed salvage lymph node dissection and adjuvant radiotherapy in nodal recurrent prostate cancer

Variables

Value

Age at salvage lymph node dissection (years)

 

 Mean/SD/median/range

64.9/5.9/65.2/75 - 53

Time from primary therapy to salvage lymph node dissection (years)

 

 Mean/SD/median/range

4.9/3.4/4.4/15.7 – 0.4

Regions affected with lymph node metastases (Histopathology) n (%)

 

 Pelvic only

31/46 (67%)

 Retroperitoneal only

5/46 (11%)

 Pelvic and retroperitoneal

9/46 (20%)

 Retroclavicular and retroperitoneal

1/46 (2%)

Number of lymph nodes removed per surgery

 

 Mean/SD/median/range

29.3/14.6/29.5/2 - 62

Number of removed lymph nodes metastases per surgery

 

 Mean/SD/median/range

7.9/4.5/8.6/1 - 44

PSA at salvage lymph node dissection (ng/ml)

 

 Mean/SD/median/range

8.7/14.5/3.2/0.57 – 72.62